Pharma Markets

Global Osteoarthritis Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Global Osteoarthritis Market and Competitive Landscape – 2020, provides comprehensive insights into Osteoarthritis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Osteoarthritis market size and drug sales. It also provides insights into Osteoarthritis epidemiology and late stage pipeline.

This research covers the following – Osteoarthritis treatment options, Osteoarthritis late stage clinical trials pipeline, Osteoarthritis prevalence by countries, Osteoarthritis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Osteoarthritis pipeline: Find out drugs in clinical trials for Osteoarthritis by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Osteoarthritis epidemiology: Find out number of patients diagnosed (prevalence) with Osteoarthritis by countries
– Osteoarthritis drugs: Identify key drugs marketed and prescribed for Osteoarthritis by countries, including trade name, molecule name, and company
– Osteoarthritis drugs sales: Find out the sales value for Osteoarthritis drugs by countries
– Osteoarthritis market valuations: Find out the market size for Osteoarthritis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Osteoarthritis drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Osteoarthritis drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Osteoarthritis market
– Develop in-depth knowledge of competition and markets
– Analyze Osteoarthritis drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Osteoarthritis market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Osteoarthritis Treatment Options
2. Osteoarthritis Pipeline Insights
2.1. Osteoarthritis Phase 3 Clinical Trials
2.2. Osteoarthritis Phase 2 Clinical Trials
2.3. Osteoarthritis Phase 1 Clinical Trials
3. Osteoarthritis Epidemiology Analysis by Countries
4. US Osteoarthritis Market Insights
4.1. Marketed Drugs for Osteoarthritis in US
4.2. US Osteoarthritis Market Size & Forecast
4.3. US Osteoarthritis Drugs Sales & Forecast
4.4. US Osteoarthritis Market Share Analysis
5. Germany Osteoarthritis Market Insights
5.1. Marketed Drugs for Osteoarthritis in Germany
5.2. Germany Osteoarthritis Market Size & Forecast
5.3. Germany Osteoarthritis Drugs Sales Forecast
5.4. Germany Osteoarthritis Market Share Analysis
6. France Osteoarthritis Market Insights
6.1. Marketed Drugs for Osteoarthritis in France
6.2. France Osteoarthritis Market Size & Forecast
6.3. France Osteoarthritis Product Sales Forecast
6.4. France Osteoarthritis Market Share Analysis
7. Italy Osteoarthritis Market Insights
7.1. Marketed Drugs for Osteoarthritis in Italy
7.2. Italy Osteoarthritis Market Size & Forecast
7.3. Italy Osteoarthritis Product Sales Forecast
7.4. Italy Osteoarthritis Market Share Analysis
8. Spain Osteoarthritis Market Insights
8.1. Marketed Drugs for Osteoarthritis in Spain
8.2. Spain Osteoarthritis Market Size & Forecast
8.3. Spain Osteoarthritis Product Sales Forecast
8.4. Spain Osteoarthritis Market Share Analysis
9. UK Osteoarthritis Market Insights
9.1. Marketed Drugs for Osteoarthritis in UK
9.2. UK Osteoarthritis Market Size & Forecast
9.3. UK Osteoarthritis Product Sales Forecast
9.4. UK Osteoarthritis Market Share Analysis
10. Europe Osteoarthritis Market Insights
10.1. Europe Osteoarthritis Market Size & Forecast
10.2. Europe Osteoarthritis Product Sales Forecast
10.3. Europe Osteoarthritis Market Share Analysis
11. Japan Osteoarthritis Market Insights
11.1. Marketed Drugs for Osteoarthritis in Japan
11.2. Japan Osteoarthritis Market Size & Forecast
11.3. Japan Osteoarthritis Product Sales Forecast
11.4. Japan Osteoarthritis Market Share Analysis
12. Global Osteoarthritis Market Insights
12.1. Global Osteoarthritis Market Size & Forecast
12.2. Global Osteoarthritis Product Sales Forecast
12.3. Global Osteoarthritis Market Share Analysis
13. Research Methodology

List of Tables


1: Osteoarthritis Phase 3 Clinical Trials, Global, 2020
2: Osteoarthritis Phase 2 Clinical Trials, Global, 2020
3: Osteoarthritis Phase 1 Clinical Trials, Global, 2020
4: Osteoarthritis Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Osteoarthritis in US, 2019
6: US Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
7: US Osteoarthritis Product Sales ($mn), 2016 – 2025
8: US Osteoarthritis Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Osteoarthritis in Germany, 2019
10: Germany Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
11: Germany Osteoarthritis Product Sales ($mn), 2016 – 2025
12: Germany Osteoarthritis Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Osteoarthritis in France, 2019
14: France Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
15: France Osteoarthritis Product Sales ($mn), 2016 – 2025
16: France Osteoarthritis Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Osteoarthritis in Italy, 2019
18: Italy Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
19: Italy Osteoarthritis Product Sales ($mn), 2016 – 2025
20: Italy Osteoarthritis Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Osteoarthritis in Spain, 2019
22: Spain Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
23: Spain Osteoarthritis Product Sales ($mn), 2016 – 2025
24: Spain Osteoarthritis Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Osteoarthritis in UK, 2019
26: UK Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
27: UK Osteoarthritis Product Sales ($mn), 2016 – 2025
28: UK Osteoarthritis Market Events and Trends, 2016 – 2025
29: Europe Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
30: Europe Osteoarthritis Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Osteoarthritis in Japan, 2019
32: Japan Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
33: Japan Osteoarthritis Product Sales ($mn), 2016 – 2025
34: Japan Osteoarthritis Market Events and Trends, 2016 – 2025
35: Global Osteoarthritis Market Size & Forecast ($mn), 2016 – 2025
36: Global Osteoarthritis Product Sales ($mn), 2016 – 2025

List of Figures


1: Osteoarthritis Pipeline by Phase (%), Global, 2020
2: Osteoarthritis Prevalence by Countries, 2016 – 2025
3: US Osteoarthritis Market Size ($mn), 2016 – 2025
4: US Osteoarthritis Product Sales ($mn), 2016 – 2025
5: US Osteoarthritis Market Share by Drugs (%), 2019
6: US Osteoarthritis Market – Future Market Share (%), 2025
7: Germany Osteoarthritis Market Size ($mn), 2016 – 2025
8: Germany Osteoarthritis Product Sales ($mn), 2016 – 2025
9: Germany Osteoarthritis Market Share by Drugs (%), 2019
10: Germany Osteoarthritis Market – Future Market Share (%), 2025
11: France Osteoarthritis Market Size ($mn), 2016 – 2025
12: France Osteoarthritis Product Sales ($mn), 2016 – 2025
13: France Osteoarthritis Market Share by Drugs (%), 2019
14: France Osteoarthritis Market – Future Market Share (%), 2025
15: Italy Osteoarthritis Market Size ($mn), 2016 – 2025
16: Italy Osteoarthritis Product Sales ($mn), 2016 – 2025
17: Italy Osteoarthritis Market Share by Drugs (%), 2019
18: Italy Osteoarthritis Market – Future Market Share (%), 2025
19: Spain Osteoarthritis Market Size ($mn), 2016 – 2025
20: Spain Osteoarthritis Product Sales ($mn), 2016 – 2025
21: Spain Osteoarthritis Market Share by Drugs (%), 2019
22: Spain Osteoarthritis Market – Future Market Share (%), 2025
23: UK Osteoarthritis Market Size ($mn), 2016 – 2025
24: UK Osteoarthritis Product Sales ($mn), 2016 – 2025
25: UK Osteoarthritis Market Share by Drugs (%), 2019
26: UK Osteoarthritis Market – Future Market Share (%), 2025
27: Europe Osteoarthritis Market Size ($mn), 2016 – 2025
28: Europe Osteoarthritis Product Sales ($mn), 2016 – 2025
29: Europe Osteoarthritis Market Share by Drugs (%), 2019
30: Europe Osteoarthritis Market – Future Market Share (%), 2025
31: Japan Osteoarthritis Market Size ($mn), 2016 – 2025
32: Japan Osteoarthritis Product Sales ($mn), 2016 – 2025
33: Japan Osteoarthritis Market Share by Drugs (%), 2019
34: Japan Osteoarthritis Market – Future Market Share (%), 2025
35: Global Osteoarthritis Market Size ($mn), 2016 – 2025
36: Global Osteoarthritis Product Sales ($mn), 2016 – 2025
37: Global Osteoarthritis Market Share by Drugs (%), 2019
38: Global Osteoarthritis Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies